Citations

Showing 10 of 108094 citations.

P839: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN SHOW IMPROVEMENTS IN D-DIMER NORMALIZATION AND DECREASE IN INCIDENCE OF THROMBOSIS
Weitz, Ilene C. , Al-Adhami, M., Min, J.S, Persson, E., Yeh, M., Savage, J., Dingli, D., Persson, Eilif

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 733-734

10.1097/01.hs9.0000846240.50953.6f Get It

P881: CDK7 CONTRIBUTES TO METABOLIC REPROGRAMMING IN MM CELLS THROUGH C-MYC MEDIATED TRANSCRIPTIONAL CONTROL OF GLYCOLYTIC GENES
YAO, Yu, Ng, J. Fong, Park, W. D., Gramegna, D., Samur, A., Samur, M., Morelli, E., Chesi, M., Mitsiades, C., Anderson, K. C., Lin, Cici, Munshi, N., Fulciniti, M., Yao, Y., Chesi, Marta , Mitsiades, Constantine S. , Munshi, Nikhil C.

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 773-774

10.1097/01.hs9.0000846400.43498.af Get It

P884: POTENTIAL BENEFIT OF POST-TRANSPLANT DOXYCYCLINE IN AL ACHIEVING HEMATOLOGICAL RESPONSE AFTER AUTOLOGOUS STEM CELL TRANSPLANT – LONG TERM FOLLOW UP
Abdallah, N., Muchtar, E., Buadi, F., Kapoor, P., Lacy, M., Hwa, Y., Fonder, A., Hobbs, M., Hayman, S., Dingli, D., Go, R., Lin, Y., Gonsalves, W., Binder, M., Kourelis, T., Warsame, R., Kyle, R., Rajkumar, S., Gertz, M., Kumar, S., Dispenzieri, Angela , Muchtar, Eli , Lacy, M. Q., Fonder, Amie , Leung, Nelson , Dingli, David , Gonsalves, Wilson I. , Kourelis, Taxiarchis , Rajkumar, S., Gertz, Morie A.

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 776-777

10.1097/01.hs9.0000846412.15297.aa Get It

P908: FACTORS ASSOCIATED WITH THE CLINICAL PROGNOSTIC PERFORMANCE OF MINIMAL RESIDUAL DISEASE ASSESSMENT BY NEXT GENERATION FLOW CYTOMETRY IN MULTIPLE MYELOMA
Nandakumar, Brunda, Baranwal, A., Ebraheem, Maher Hassan, Olteanu, Horatiu , Kumar, Shaji , Jevremovic, D., Baranwal, A., Shi, Min , Gonsalves, Wilson I. , Jevremović, Dragan

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 799-800

10.1097/01.hs9.0000846504.49611.cf Get It

P936: TIME TO RESPONSE, DURATION OF RESPONSE, AND PATIENT-REPORTED OUTCOMES WITH DARATUMUMAB PLUS RD VS RD ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NDMM: SUBGROUP ANALYSIS OF THE PHASE 3 MAIA STUDY
Facon, T., Kumar, Seema, Plesner, Torben , Goldschmidt, H., Perrot, A., Venner, Chris , Mace, Joseph R., Tiab, Mourad, Macro, M. , Frenzel, L., Leleu, Xavier , Pei, H., Borgsten, F., Usmani, S. Z., Moreau, Philippe , Bahlis, Nizar Jacques , O’Dwyer, Michael , Weisel, Katja C , Raje, Noopur

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 826-827

10.1097/01.hs9.0000846612.13339.9e Get It

P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY
Lin, Yaxiong, Martin, Thomas , Berdeja, J. G., Deol, Abhinav , Htut, Myo, Munshi, Nikhil C. , O’Donnell, Elisabeth K., Jackson, C. C., Yeh, Tzu‐Min, Banerjee, Arnob , Zudaire, Enrique, Pacaud, Lida , Usmani, S. Z., Jakubowiak, Andrzej , Agha, Mounzer , Cohen, Adam D. , Htut, Myo , Lesokhin, Alexander M. , Jackson, C.C., Madduri, Deepu , Zhou, C., Jagannath, Sundar

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 851-852

10.1097/01.hs9.0000846712.74284.0f Get It

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE
Lacy, M. , Fonder, Amie , Hobbs, Miriam, Hayman, S. R., hwa, L. Y., Kouralis, T., Warsame, Rahma , Nelson, Lauren Juliette Hassan, Kapoor, Prashant , Grogan, Martha , Siddiqi, Mustaqeem A, Robert, K., Vaxman, Iuliana , Kumar, Subodh , Buadi, Francis K. , Dingli, David , Muchtar, Eli , Go, Ronald S. , Gonsalves, Wilson I. , Rajkumar, S. Vincent , Gertz, Morie A. , Dispenzieri, Angela

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 856-857

10.1097/01.hs9.0000846732.06415.be Get It

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)
Hoering, Antje , Sexton, Rachel , Valent, Jason , Rosenzweig, M., Zonder, Jeff, Dhodapkar, M., Zimmerman, T., Voorhees, Peter M. , Durie, Brian, Richardson, PG, Usmani, Saad Z. , Ailawadhi, Sikander , Sexton, R., Lipe, Brea , Valent, Jason Neil , Rosenzweig, Michael , Callander, Natalie S. , Rajkumar, S. Vincent , Orlowski, Robert Z.

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 855-856

10.1097/01.hs9.0000846728.05693.f8 Get It

P968: ADDITION OF IXAZOMIB TO POMALIDOMIDE AND DEXAMETHASONE IMPROVES PROGRESSION-FREE SURVIVAL FOR MULTIPLE MYELOMA PATIENTS PROGRESSING ON LENALIDOMIDE AS PART OF 1ST LINE THERAPY: ALLIANCE A061202
Voorhees, Peter M. , Suman, V., Efebera, Y., Raje, N., Rodriguez, Carlos A. , Santo, K., Bova‐Solem, Misty, Carlisle, Destin, Saad, Ullah, McCarthy, Phillip, Richardson, PG, Suman, V., Efebera, Yvonne A. , Tuchman, Sascha Alexander

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 858-859

10.1097/01.hs9.0000846740.75414.50 Get It

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA
Weisel, K., Mateos, María‐Victoria , Martin, Thomas , Berdeja, J. G., Lin, Yi , Thilakarathne, Pushpike, Diels, Joris , Haefliger, B., Hague, Clare, Gonzalez, A., Schecter, Jordan M. , Gries, Katharine S. , Strulev, Vadim, Nesheiwat, Tonia, Pacaud, Lida , Einsele, H., Moreau, P., Vincent, Laure , Jakubowiak, Andrzej , Jagannath, Sundar , Ghilotti, Francesca , Moreau, P.

Mayo Clinic

HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 861-862

10.1097/01.hs9.0000846752.50612.48 Get It